It has been confirmed that NLRP3 inflammasome is activated since the onset of ischemic stroke (Fann et al., 2013b), and treatments targeting NLRP3 inflammasome are found to be promising for the treatment of stroke (Yang et al., 2014). The gene discussed is NLRP3; the disease is ischemic stroke.